gene product
beta4Gal-T1, GGTB2
This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene is unique among the beta4GalT genes because it encodes an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Two transcripts, which differ only at the 5' end, with approximate lengths of 4.1 kb and 3.9 kb encode the same protein. The longer transcript encodes the type II membrane-bound, trans-Golgi resident protein involved in glycoconjugate biosynthesis. The shorter transcript encodes a protein which is cleaved to form the soluble lactose synthase. [provided by RefSeq, Jul 2008]
More gene data





Antibodypedia Validation Initiative

Validation method





Antibody type


  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
162 antibodies from 25 providers.

Antibody properties



or Cancel
Atlas Antibodies
2 antibodies
Novus Biologicals
5 antibodies
Enzo Life Sciences
1 antibody
59 antibodies
Abnova Corporation
2 antibodies
Invitrogen Antibodies
4 antibodies
R&D Systems
3 antibodies
13 antibodies
Affinity Biosciences
1 antibody
2 antibodies
LifeSpan BioSciences, Inc.
25 antibodies
Aviva Systems Biology
3 antibodies
1 antibody
1 antibody
1 antibody
NovoPro Bioscience Inc.
6 antibodies
Creative Biolabs
4 antibodies
Boster Biological Technology
2 antibodies
St John's Laboratory
2 antibodies
Creative Diagnostics
4 antibodies
2 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
2 antibodies
United States Biological
12 antibodies
Sino Biological Inc.
4 antibodies